We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Bladder Cancer

Journal Scan / Research · August 10, 2021

Safety and Efficacy of Atezolizumab in Understudied Populations With Pretreated Urinary Tract Carcinoma

The Journal of Urology

 

Additional Info

The Journal of Urology
Safety and Efficacy of Atezolizumab in Understudied Populations With Pretreated Urinary Tract Carcinoma: Subgroup Analyses of the SAUL Study in Real-World Practice
J Urol 2021 Aug 01;206(2)240-251, AS Merseburger, D Castellano, T Powles, Y Loriot, M Retz, J Voortman, RA Huddart, C Gedye, MS Van Der Heijden, H Gurney, M Ong, S de Ducla, J Pavlova, S Fear, CN Sternberg

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading